[go: up one dir, main page]

Chism et al., 1976 - Google Patents

Analysis of murine oncofetal antigens as tumor-associated transplantation antigens

Chism et al., 1976

View PDF
Document ID
10196653097624511313
Author
Chism S
Wallis S
Burton R
Warner N
Publication year
Publication venue
The Journal of Immunology

External Links

Snippet

In previous studies with in vitro activated cytotoxic T lymphocytes, we have demonstrated the presence of oncofetal antigens (OFA) on a range of murine tumor cells. The present studies with the same tumor lines attempt to determine whether these antigens are also capable of …
Continue reading at scholar.archive.org (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients

Similar Documents

Publication Publication Date Title
MORTON et al. Immunological aspects of neoplasia: A rational basis for immunotherapy
Van Boxel et al. Antibody-dependent lymphoid cell-mediated cytotoxicity: no requirement for thymus-derived lymphocytes
Bhan et al. The role of T cell sets in the rejection of a methylcholanthrene-induced sarcoma (S1509a) in syngeneic mice
Chism et al. Analysis of murine oncofetal antigens as tumor-associated transplantation antigens
Nelson et al. Thy and Ly markers on lymphocytes initiating tumor rejection
Yamagishi et al. Effect of splenectomy upon tumor growth: characterization of splenic tumor-enhancing cells in vivo
Jurin et al. In vivo and in vitro studies of the influence of the immune status of C3Hf/Bu mice on the effectiveness of local irradiation of a methylcholanthrene-induced fibrosarcoma
Perry et al. Mechanisms of regulation of cell-mediated immunity: anti-IA alloantisera interfere with induction and expression of T-cell-mediated immunity to cell-bound antigen in vivo
Hilal et al. Surgical adjuvant therapy of malignant melanoma with Corynebacterium parvum
Perry et al. Enhanced syngeneic tumor destruction by in vivo inhibition of suppressor T cells using anti-IJ alloantiserum
Daynes et al. Cell-mediated immune response to syngeneic ultraviolet-induced tumors: II. The properties and antigenic specificities of cytotoxic T lymphocytes generated in vitro following removal from syngeneic tumor-immunized mice
Kirchner et al. Defective in vitro spleen cell proliferative response to antigens in agammaglobulinemic chickens
Castro et al. Orchidectomy as a method of immunopotentiation in mice
Herseys et al. Current status and future prospects for adjuvant therapy of melanoma
Robinson et al. Synergistic cytolytic activity by combined populations of peritoneal T lymphocytes and macrophages during the L5178Y cell tumor-dormant state in DBA/2 mice
Halliday Immunological enhancement, blocking factors, and tolerance to tumours, transplants and foetuses
Gautam et al. T-cell-mediated antitumor immune response induced by oncofetal antigens
Milas et al. Therapy of artificial and spontaneous metastases of murine tumors with maleic anhydride-divinyl ether-2
Olsson et al. Immunoadjuvant Treatment of Primary Grafted and Spontaneous AKR-Leukemia: I. Treatment Efficiency Correlated to Autoimmune Reactivity
Argyris et al. Lack of suppressor cell activity in the spleens of mice with radiation-induced osteogenic sarcomas
Tevethia et al. Macrophages and the destruction of syngeneic virus-induced tumors
Martin et al. Immunoprophylaxis and therapy of grafted rat colonic carcinoma.
de Jong et al. T-cell involvement in adoptive transfer of line 10 tumor immunity in strain 2 guinea pigs
Abramoff et al. Detection of antigenically distinctive components of mouse melanoma S91
Tracey et al. Growth of transplanted rat tumors following administration of cell-free tumor antigens